Long term efficacy and safety of cyclosporin versus parenteral old in early rheumatoid arthritis: a three year study of radiographic progression, renal function, and arterial hypertension
Objective: To compare the three year safety and efficacy of cyclosporin and parenteral gold in the treatment of early, active, severe rheumatoid arthritis (RA), and to study the reversibility of cyclosporin associated renal dysfunction in patients who discontinued cyclosporin treatment. Methods: The patients continued to receive cyclosporin or parenteral gold in an 18 month open extension to an 18